Robert Ferrara L.'s most recent trade in Phio Pharmaceuticals Corp was a trade of 23,100 Common Stock, $.0001 par value done . Disclosure was reported to the exchange on Sept. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phio Pharma Corp | Robert Ferrara L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 23,100 | 38,766 (2%) | 1% | 0 | Common Stock, $.0001 par value | |
| Phio Pharma Corp | Robert L. Ferrara | Director | Purchase of securities on an exchange or from another person at price $ 2.42 per share. | 10 Jun 2025 | 2,500 | 15,666 (0%) | 0% | 2.4 | 6,050 | Common stock, $0.0001 par value |
| Phio Pharma Corp | Robert L. Ferrara | Director | Purchase of securities on an exchange or from another person at price $ 1.82 per share. | 20 May 2025 | 2,500 | 13,166 (0%) | 0% | 1.8 | 4,550 | Common stock, $0.0001 par value |
| Phio Pharma Corp | Robert L. Ferrara | Director | 11 Sep 2024 | 10,000 | 10,000 (0%) | 0% | 0 | Common stock, $0.0001 par value | ||
| Phio Pharma Corp | Robert L. Ferrara | Director | 14 Jun 2023 | 2,000 | 6,000 (0%) | 0% | 3.1 | 6,200 | Common stock, $0.0001 par value | |
| Phio Pharma Corp | Robert L. Ferrara | Director | 17 Feb 2023 | 1,500 | 4,000 (0%) | 0% | 0 | Common stock, $0.0001 par value | ||
| Phio Pharma Corp | Robert L. Ferrara | Director | 02 Dec 2022 | 5,000 | 30,000 (1%) | 0% | 0.4 | 2,041 | Common stock, $0.0001 par value | |
| Phio Pharma Corp | Robert L. Ferrara | Director | 23 Nov 2022 | 2,000 | 25,000 (1%) | 0% | 0.4 | 820 | Common stock, $0.0001 par value | |
| Phio Pharma Corp | Robert L. Ferrara | Director | 15 Feb 2022 | 10,000 | 23,000 (1%) | 0% | 0 | Common stock, $0.0001 par value | ||
| Phio Pharma Corp | Robert L. Ferrara | Director | 01 Mar 2021 | 10,000 | 12,318 (0%) | 0% | 0 | Common stock, $0.0001 par value | ||
| Phio Pharma Corp | Robert L. Ferrara | Director | 01 Mar 2021 | 682 | 13,000 (0%) | 0% | 3.1 | 2,148 | Common stock, $0.0001 par value |